Cart
sales@molnova.com
JH-T4
CAS No. ——
JH-T4( —— )
Catalog No. M17043 CAS No. ——
JH-T4 is a potent small molecule SIRT2 inhibitor with IC50 of 0.3 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameJH-T4
-
NoteResearch use only, not for human use.
-
Brief DescriptionJH-T4 is a potent small molecule SIRT2 inhibitor with IC50 of 0.3 uM.
-
DescriptionJH-T4 is a potent small molecule SIRT2 inhibitor with IC50 of 0.3 uM (sirtuin deacylation activity), increase intracellular K-Ras4a lysine fatty acylation; inhibited both the deacetylation and defatty-acylation activity of SIRT2 in vitro with IC50 of 30-50 nM; JH-T4 is the first small molecule inhibitor that can modulate the lysine fatty acylation levels of K-Ras4a. JH-T4 also inhibits SIRT1 and SIRT3 in vitro.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetSirtuin
-
RecptorSirtuin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight597.859
-
Molecular FormulaC34H51N3O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OCC1=CC=CC=C1)N[C@@H](CCCCNC(CCCCCCCCCCCCC)=S)C(NC2=CC=CC(O)=C2)=O
-
Chemical Namebenzyl (S)-(1-((3-hydroxyphenyl)amino)-1-oxo-6-tetradecanethioamidohexan-2-yl)carbamate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Spiegelman NA, et al. ChemMedChem. 2019 Feb 7. doi: 10.1002/cmdc.201800715.
molnova catalog
related products
-
SIRT-IN-2
SIRT-IN-2 is a potent SIRT1/2/3 inhibitor(IC50s of 4, 1, 7 μM, respectively).
-
Benzamide, 3-methoxy...
Benzamide, 3-methoxy-N-(3-thiazolo[5,4-b]pyridin-2-ylphenyl) is a sirtuin modulator and useful for increasing the lifespan of a cell, and treating and?/or preventing a wide variety of diseases and disorders including diabetes, cardiovascular disease.
-
Ophiopogonin D (b)
Ophiopogonin D' can activate SIRT1 in a dose-dependent manner. Ophiopogonin D' also noncompetitively inhibits UGT1A6 and UGT1A10.
